Improved Survival in Congenital Heart Disease

Explore a comprehensive conference talk on the advancements in survival rates for congenital heart disease patients. Delve into the remarkable progress made in pediatric critical care, resulting in a 97-98% survival rate across major academic centers. Examine the long-term implications of these improvements, including neurodevelopmental outcomes and quality of life for patients who are corrected but not cured. Investigate the persistent risk of neurodevelopmental impairment in children with congenital heart disease, despite improved management techniques. Learn about the factors contributing to these risks, including genetic abnormalities, changes in fetal cerebral hemodynamics, and ongoing research into fetal interventions. Gain insights into the challenges faced by adults with congenital heart disease and the potential impact on critical care practices.